Multihance Multipack (gadobenate dimeglumine)
Intravenous Vial (ML)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This medication is used before a magnetic resonance imaging (MRI) scan. It belongs to a class of drugs known as gadolinium-based contrast agents (GBCAs). This medication helps the MRI scan make clearer images, so your doctor can more easily diagnose your condition.
Generic name: gadobenate dimeglumine
Therapeutic class: Diagnostic Agents
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Multihance Multipack
Indications
The following indications are listed for Multihance Multipack:
- Diagnostic Imaging
Also known as: Diagnostic Imaging Exam, Diagnostic Imaging Procedure, Diagnostic Radiography, Diagnostic Radiology.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Acute renal failure
- Chronic kidney disease stage 4 (severe) GFR 15-29 ml/min
- Nephrogenic systemic fibrosis
- Congenital long QT syndrome
- Kidney disease with likely reduction in glomerular filtration rate (GFr)
- Asthma
- Cardiac arrhythmia
- Disease of liver
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Acute pancreatitis
- Acute respiratory distress syndrome
- Anaphylaxis
- Dyspnea
- Extravasation injury
- Facial edema
- Hypersensitivity drug reaction
- Nephrogenic systemic fibrosis
- Paresthesia
- Pulmonary edema
- Seizure disorder
- Tongue swelling
Less Frequent
- Headache disorder
- Nausea
Rare or Very Rare
- Abdominal pain with cramps
- Cardiac arrhythmia
- Chest pain
- Chills
- Diarrhea
- Dizziness
- Dysgeusia
- Fatigue
- General weakness
- Hyperhidrosis
- Hypertension
- Injection site sequelae
- Laryngismus
- Malaise
- Myalgia
- Nasal congestion
- Ocular inflammation
- Ocular itching
- Pain
- Parosmia
- Pruritus of skin
- Skin plaque
- Skin rash
- Tinnitus
- Tremor
- Urticaria
- Visual changes
- Vomiting
- Wheezing
- Xerostomia
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.